In addition, for colorectal cancer, FUNDC1 only had a protective effect on RFS for rectum adenocarcinoma (READ) (OS: HR = 2.01, 95% CI from 0.6 to 6.7, logrank P = 0.25; RFS: HR = 0.18, 95% CI from 0.03 to 1.04, logrank P = 0.033) (Figures 3O,P). Here, FUNDC1 is linked to colorectal cancer.